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Neurological disorders induced by long-term exposure to organic solvents typically have a slowly progressive 
clinical course, which may be arrested or even reversed following discontinuation of exposure. We report an unusual 
case of rapidly progressive toxic leukoencephalomyelopathy in a 29-year-old man who had worked at a chemical 
factory that used toluene for the manufacture of nylon 66 for 5 years. He presented with progressive weakness of 
legs, recurrent seizures, and cognitive decline. Widespread white-matter changes in the brain and spinal cord, and 
myelodysplastic syndrome were noted. He died 6 months after the onset of his symptoms, and autopsy showed 
discrete multifocal demyelination and necrosis in the central nervous system, and dysplastic cells of erythroid, 
myeloid, and megakaryotic lineages in blood vessels. The co-occurrence of leukoencephalomyelopathy and 
myelodysplastic syndrome highlights the vulnerability of the white matter and bone marrow to injury from organic 
solvents. Intravascular congestion of dysplastic hematopoietic cells might have led to his unusually rapid progression 
of leukoencephalomyelopathy.
J Clin Neurol 3(1):45-49, 2007
Key Words : Toxic leukoencephalomyelopathy, Organic solvent, Toluene, Myelodysplastic syndrome
Received : September 14, 2006 / Accepted : December 18, 2006 / Address for correspondence : Beom S. Jeon, M.D., Ph.D.
Department of Neurology, Seoul National University Hospital Yongon-dong 28, Chongno-gu, Seoul, 110-744, Korea
Tel: +82-2-2072-2876,  Fax: +82-2-3672-7553, E-mail: brain@snu.ac.kr
Organic solvents are used in various occupational 
settings, and brain damage resulting from long-term 
exposure to organic solvents is a health concern to many 
workers. There are numerous clinical reports
1–10 and 
experimental studies
11,12 of organic solvent-induced 
disorders involving the central nervous system (CNS), 
peripheral nervous system (PNS), and autonomic 
nervous system, and bone marrow and other organs. 
Neurological disorders induced by toxins typically 
run a monophasic course. Although progression may 
occur for several weeks after discontinuation of ex-
posure, it is eventually arrested, after which improve-
ment may follow.
1
Here we describe an unusual case of rapidly pro-
gressiveleukoencephalomyelopathy coexisting with mye-
lodysplastic syndrome (MDS) following chronic exposure 
to organic solvents, and discuss the pathogenetic inter-
connection between these conditions.
CASE DESCRIPTION
A 29-year-old man was admitted due to progressive 
weakness of both legs over the previous 4 months, and 
cognitive decline and recurrent seizures over the 
previous month. The weakness had started in his right Journal of Clinical Neurology: Vol. 3, No. 1, 2007
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Figure 1. Cranial axial T2-weighted MRI images show multiple high-intensity signals in the periventricular 
white matter and symmetric hypointensities in the thalamus (A, C), and a T1-weighted MRI image shows 
multifocal calcification in the periventricular white matter (B). Follow-up brain MRI performed 3 months later 
(D–F) shows more extensive, bilateral, and symmetrical high-intensity signals in the white matter. Note that 
the differentiation between the gray and white matter is preserved. Spinal T1-weighted MRI image shows mild 
atrophy (G), and T2-weighted MRI reveals extensive high-intensity signals throughout the spine (H).
leg and gradually spread to the left side over 1 month. 
Cranial and spinal magnetic resonance imaging (MRI) 
performed at another institution 3 months prior to 
admission to our hospital showed multifocal high–
intensity signals in the white matter on T2-weighted 
imaging (Fig. 1A–C). Cerebrospinal fluid (CSF) 
parameters including the IgG index and oligoclonal band 
were normal. The score on the Korean version of the 
Mini-Mental State Examination (K-MMSE) was 27/30 
(education length: 15 years). Intravenous methylpredni-
solone treatment was given, but the weakness worsened, 
and generalized tonic-clonic seizures occurred 1 month 
prior to admission. He was transferred to another 
hospital. Repeated application of the K-MMSE showed 
a severe decline in cognitive function (9/30), and ab-
dominal distension was detected 10 days prior to 
admission. Abdominal computed tomography revealed 
hepatosplenomegaly, ascites, and pleural effusions. The 
ascitic fluid was transudate. He was then transferred to 
our hospital.
He had no specific history of medical or neurological 
disease, and took no illicit drugs. A family history was 
absent, but his occupational history was notable. He had 
worked at a chemical factory manufacturing nylon 66 
for 5 years, resulting in exposure to toluene. However, 
no information was available on the degree of exposure 
of either the patient or his coexposed workers. A 
neurological examination revealed severe apathy, 
disorientation to time and place, dementia (K-MMSE: 
9/30), decreased visual sensitivity in both eyes but with 
normal papillary reflex, flaccid paraplegia with no 
sensory perception below level T4 of the spinal cord, 
and bilateral extensor toe sign. 
Routine blood tests were normal except for mild 
leukocytosis (11,000 cells/mm
3). Rheumatoid factor, 
anti-Ro/La, anti-Sm, antimitochondrial, antinuclear, and 
anti-double-stranded DNA antibodies, HIV test, very- 
long-chain fatty acid, arylsulfatase A, beta-galactosidase, 
and CSF profiles were normal. His visual evoked 
potential revealed the presence of bilateral retrochiasmal 
lesions. Cranial T2-weighted MRI showed more ex-
tensive and symmetric high-intensity signals in the 
periventricular white matter than in his previous MRI 
scans, and symmetric hypointensities in the thalamus 
(Fig. 1-D, F). Spinal T2-weighted MRI also revealed 
extensive high-intensity signals throughout the spine 
with mild atrophy. Electromyography and nerve con-
duction studies were normal (Fig. 1-G, H).
He became febrile (39℃) on his 6
th hospital day 
(HD). Anemia (Hb: 9.1 g/dl) and thrombocytopenia 
(79,000 platelets/mm
3) were detected. A peripheral-blood 
morphology examination showed macrocytic, normoJung KH, et al. Rapidly Progressive Toxic Leukoencephalomyelopathy with Myelodysplastic Syndrome
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Figure 2. Coronal cross section of the brain shows diffuse gray-yellow discoloration and softening of the white 
matter (A). The white matter shows a diffuse area of necrosis (white arrowheads) with dystrophic calcification 
(black arrowheads; B), and the high-magnification view of the necrotic white matter shows rarefaction 
and occasional reactive astrocytes (white arrow; C). The cerebral blood vessel was filled with dysplastic 
hematopoietic cells. (D) Black arrow indicates a foam cell in the necrotic white matter.
chromic red blood cells with anisocytosis and poly-
chromasia. Ascites, hepatomegaly, and pleural effusions 
worsened. A needle liver biopsy performed on the 10
th 
HD showed nonspecific reactive hepatitis. Despite 
transfusion, the thrombocytopenia and anemia worsened 
(Hb: 8.3 g/dl; 58,000 platelets/mm
3), and his cognitive 
functions deteriorated. Recurrent generalized tonic 
seizures occurred after the administration of multiple 
antiepileptic drugs. On the 30
th HD he did not respond 
to visual threatening despite his pupils being reactive. 
He was abulic and akinetic. On the 55
th HD he died of 
uncontrolled pneumonia, and a postmortem examination 
was performed.
RESULTS  OF PATHOLOGICAL STUDIES
The unfixed cerebrum and cerebellum weighed 1,165 
and 390 g, respectively. The meninges were not opa-
cified. Coronal sections (Fig. 2-A) showed bilateral, 
discrete, and friable gray-yellow discolored foci in the 
white matter that was accompanied by punctate 
hemorrhage. The brainstem was grossly unremarkable, 
but multiple, discrete, and confluent foci of necrosis and 
demyelination were observed microscopically (Fig. 2-B, 
D) that were randomly scattered in the subcortical and 
deep white matter of the cerebrum, cerebellum, brain-
stem, and spinal cord. These foci were associated with 
collections of foamy histiocytes and dystrophic calci-
fication. The adjacent, relatively uninvolved parenchyma 
showed patchy spongiform changes and reactive astro-
cytosis. Blood vessels were filled with dysplastic cells of 
erythroid, myeloid, and megakaryotic lineages (Fig. 
2-D). The bone marrow was hypercellular (91–100%), 
and showed a proliferation of erythropoietic cells, 
granulopoietic cells, and megakaryocytes with dysplastic 
features, which was consistent with trilineage MDS. 
Heavy infiltrates of dysplastic hematopoietic cells were 
evident in multiple organs, including the lung, heart, 
kidney, liver, and spleen. Organizing pneumonia with 
cytomegalovirus infection was noted in both lungs.
DISCUSSION
Toxic leukoencephalopathy is an important differential Journal of Clinical Neurology: Vol. 3, No. 1, 2007
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diagnosis in any patient who presents with acute or 
chronic neurobehavioral deficits and who has a possible 
or known exposure to organic solvents.
13 In our case, the 
history of chronic occupational exposure, systemic 
involvement such as MDS and hepatitis, and the 
exclusion of other possible causes support the diagnosis 
of toxic leukoencephalopathy.
Toluene, the main constituent of glue, paint, and 
thinner, is widely recognized as an inducer of leuko-
encephalopathy.
4 Inhaled toluene is rapidly absorbed by 
the lungs and excreted as a form of hippuric acid by the 
kidney.
13  Because of its high lipid solubility, it easily 
enters highly vascularized lipid-rich tissues such as the 
brain and the bone marrow.
4,13  Therefore, toluene easily 
damages these tissues, resulting in demyelination, 
gliosis, axonal loss, and iron deposition in the nervous 
system and the malignant transformation of blood- 
forming tissue in the bone marrow. Many reports on 
toluene abusers have established that toluene caninduce 
various neurological disorders, such as encephalopathy, 
cerebellar and pyramidal signs, and peripheral neuro-
pathy.
1–5 Clinical observations have also demonstrated 
that exposure to organic solvents can cause acute 
myeloid leukemia or MDS.
6–10
Neurotoxicity disorders should be suspected when 
there is a close relationship between clinical onset and 
prior exposure to a chemical agent, especially one 
known to be neurotoxic. However, inaccurate infor-
mation on the degree and duration of exposure, ill- 
defined dose–response relation, litigation issues, and 
limitations of diagnostic methods hamper the diagnosis 
of toxic leukoencephalopathy.
1,13 The usefulness of labora-
tory testing is limited by the exposure often occurring 
years previously and no test existing to identify the sus-
pected toxin.
1 The reported MRI findings of chronic 
solvent abusers are cerebral and cerebellar atrophy, 
multifocal or diffuse white-matter changes, loss of 
demarcation between the cortex and white matter, and 
symmetric hypointensities in the thalamus or basal 
ganglia.
14 However, the radiological findings are not 
sufficiently specific to allow a conclusive diagnosis. 
Furthermore, pathological studies on solvent-induced 
leukoencephalopathy are very rare.
Kornfeld, et al. first reported the pathology of this 
disorder in three cases.
15  They described patchy 
demyelination in the white matter of the cerebral and 
cerebellar hemispheres that was associated with 
trilaminar inclusions within PAS-positive macrophages. 
A comparative study of multiple sclerosis and 
solvent-induced leukoencephalopathy produced similar 
pathological findings for the demyelination process.
16 
Experimental studies
11,12 aimed at revealing causal 
relationships showed that high-dose exposure can result 
in multifocal axonal loss, gliosis, dystrophic calci-
fication, and demyelination. These findings were also 
obtained in our case, which suggests the presence of 
aggressive pathogenesis.
Most cases of neurological disorders induced by 
organic solvents typically have a slow progression, 
whereas our patient showed a rapidly progressive disease 
course. We speculate that the coexistent MDS acce-
lerated damage to the white matter. Remarkably, intra-
cerebral vessels in the white matter were filled with 
dysplastic cells of erythroid, myeloid, and megakaryotic 
lineages. These dysplastic cells might have damaged the 
white matter by hyperviscosity leading to hemorheological 
disturbances and microvasculopathy.
17
Another interesting point was also raised by this case. 
The PNS and CNS are potential targets for solvent- 
induced neurotoxicity.
1 However, the PNS was not 
affected in this patient, and so the selective involvement 
of the CNS suggests that the PNS is more resistant to 
direct toxic injury and to ischemic damage that is 
attributed to hyperviscosity. The PNS might only 
become involved when the disease process is more 
gradual and chronic.
To the best of our knowledge, this is the first reported 
case of rapidly progressive leukoencephalomyelopathy 
induced by chronic and occupational exposure to an 
organic solvent. The unique pathological findings 
support the presence of pathogenetic interconnections 
between rapidly progressive leukoencephalomyelopathy 
and MDS. 
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